A case of ocular toxicity with vasospasm secondary to quinine poisoning is described. Therapy for vasospasm using nimodipine, hypertension, haemodilution and hypervolaemia was instituted with subsequent resolution of symptoms.
CASE HISTORY
A 53-year-old man presented to our institution with bilateral visual loss. Between 24 and 36 hours earlier he had taken approximately 4.5 g of quinine sulphate in a suicide attempt. He denied any cointoxication other than an unspecified amount of alcohol. In particular he denied any methanol consumption. He was not able to give a clear account of the events between taking the overdose and his time to presentation.
He had no previous history of neurological disorder or diabetes. On presentation he had severe bilateral visual loss without any light perception. He had associated tinnitus but no nausea or other features of cinchonism. The twelve-lead ECG was normal. He was seen by an ophthalmologist who noted that on fundoscopy his discs appeared normal and that the retinal arteries were of normal calibre but that there were cherry-red spots at the macula consistent with a period of retinal arteriolar constriction. The rest of his examination was unremarkable. He had a serum quinine level of 45 µg.ml -1 .
He was admitted to the intensive therapy unit for electrocardiographic monitoring and was administered activated charcoal every six hours for four doses.
Over the next five days he regained light perception only. At seven days, fundoscopy showed central retinal pallor, retinal arteriolar constriction and cherry red spots at the macula. On the eighth day of admission he had a dramatic improvement in his vision with the ability to count fingers and an approximate visual acuity of 6/9 bilaterally. The following day he developed a migrainous type of headache with loss of vision to the level of light perception only. Because the fluctuating nature of the patient's visual loss suggested an element of vasospasm, we commenced intravenous nimodipine (0.01 mg.kg -1 .hour -1 ), intravenous hydration with 0.9% saline to maintain a central venous pressure of at least 9 mmHg and intravenous noradrenaline to maintain a systolic blood pressure of 140-180 mmHg. The patient's vision subsequently improved to 6/9 bilaterally over the course of the next 24 hours and did not deteriorate again. Retinal blood flow appeared improved on direct fundoscopy within 12 hours of commencing therapy. Formal evaluation of his visual fields revealed marked constriction of fields with a patchy central loss and acuity of 6/9 bilaterally.
DISCUSSION
The effects of acute poisoning with quinine are well known and include cinchonsim, acute renal failure, cardiac arrythmias, death and blindness 1,2 . The ocular findings include fixed dilated pupils and reduced acuity [1] [2] [3] . The pathophysiology of ocular toxicity is not yet clear, however retinal ischaemia secondary to vasospasm and a direct toxic effect on the retinal cells have both been advanced as theories 2, 4, 5 . The natural history of blindness secondary to quinine is to improve over the course of several days leaving a permanent peripheral field defect, although central scotomas, loss of colour vision and complete monocular blindness have all been reported as sequelae 1 . Several different management strategies have been attempted without any being clearly efficacious including stellate ganglion blockade 2,5,6 , intravenous venodilators 7 and hyperbaric oxygen 8 .
Due to the lateness of this patient's presentation and the doubt surrounding the efficacy of current management strategies for quinine ocular toxicity, we initially opted for expectant management. However, because of the fluctuating nature of the visual deficit and the presence of arteriolar constriction on fundoscopy, we commenced treatment for vasospasm when his vision deteriorated. In the neurosurgical literature, vasospasm associated with subarachnoid haemorrhage is well recognised and optimal initial treatment strategies include intravenous nimodipine and induced hypertension, hypervolaemia and haemodilution 9, 10 . Such therapy has not been previously reported as therapy for quinine ocular toxicity, however use of venodilators in cases with demonstrable arteriolar constriction has been reported as successful 7 .
It may be that by treating the apparent vasospasm, vision has been preserved. Of course considering the fluctuating nature of his course and the natural history of quinine ocular toxicity, it may be that the vision would have returned regardless of therapy. This avenue of management is one that is worthy of further consideration in quinine toxicity with demonstrable vasospasm.
